Enlivex Therapeutics (ENLV)

• Market cap: $25.5M
• 1 day: -1.87%
• 5 days: -0.94%
• 1 month: 0.96%
• 3 months: -31.82%
• 6 months: 2.94%
• Year to date: -15.32%
• 1 year: -23.91%
• 5 years: -90.49%
• 10 years: -99.47%
• Sector: Healthcare
• Industry: Biotechnology

About: Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Employees: 36